Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

Delayed Quote. Delayed  - 07/29 04:59:32 pm
379.1 DKK   +0.32%
07/28 DIAMYD MEDICAL : Companion Medical receives FDA clearance
07/25 NOVO NORDISK A/ : - Share repurchase programme
07/23 NOVO NORDISK A/ : 66% of diabetes sufferers unaware
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
07/28 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Aleutian ..
07/28 STUDIES FROM NOVO NORDISK YIELD NEW : Effects of BMI, Hypertension,...
07/28 NOVO NORDISK A/S : James Shehan, Former General Counsel at Novo Nordisk, Joins L..
07/28 NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Ethanol Reported (H..
07/28 DIAMYD MEDICAL : Companion Medical receives FDA clearance
07/25 NOVO NORDISK A/S : - Share repurchase programme
07/23 NOVO NORDISK A/S : 66% of diabetes sufferers unaware
07/21 NOVO NORDISK A/S : Researchers at Novo Nordisk Report New Data on Stem Cell Rese..
07/21 NOVO NORDISK A/S : The Digital Health Connection in Africa
07/18 NOVO NORDISK A/S : - Share repurchase programme
07/14 NOVO NORDISK A/S : Unique New Book Series from Novo Nordisk and JDRF Uses Custom..
07/12 NOVO NORDISK A/S : to present 28 abstracts at the World Federation of Hemophilia..
07/11 NOVO NORDISK A/S : - Share repurchase programme
07/07 NOVO NORDISK A/S : Inc. Partners with Tony Award®-Winning Actor and Entertainer ..
07/07 NOVO NORDISK A/S : Findings on Hormones Reported by Investigators at Novo Nordis..
07/07 NOVO NORDISK A/S : Reports from Novo Nordisk Provide New Insights into Hypoglyce..
07/07 NOVO NORDISK A/S : Partnerships Are the New Black
07/05 NOVO NORDISK A/S : invests $ 59 mn to expand insulin plant in Denmark
07/04 NOVO NORDISK A/S : invests DKK 400 million in an expanded production plant in Ka..
07/01 NOVO NORDISK A/S : and Aarhus University team up for protein technology R&D
07/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
07/01 NOVO NORDISK A/S : - Share repurchase programme
06/29 NOVO NORDISK A/S : Scores One for Partnerships
06/29 Novo Nordisk eyes technology tie-ups
06/29 Novo Nordisk eyes technology tie-ups
06/28 NOVO NORDISK A/S : EMA grants marketing authorisation of mylife(TM) YpsoPump® fo..
06/27 NOVO NORDISK A/S : - Share repurchase programme
06/26 NOVO NORDISK A/S : Danish healthcare organization seeks to expand collaboration ..
06/25 NOVO NORDISK A/S : Danish health team seeks cooperation beyond merely treating d..
06/23 NOVO NORDISK A/S : Patent Issued for Regeneration of Chromatographic Stationary ..
06/20 NOVO NORDISK A/S : - Share repurchase programme
06/16 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Type 2 Di..
06/16 NOVO NORDISK A/S : Study Findings on Mycoplasma Are Outlined in Reports from Nov..
06/16 NOVO NORDISK DETAILS FINDINGS IN TYP : Clinical Pharmacokinetics and Pharmacodyn..
06/16 BRENNTAG : Specialties Inc. (BSI) Expands Pharmaceutical, Over-the-Counter (OTC)..
06/14 NOVO NORDISK A/S : Team Novo Nordisk Seeks Young Athletes with Type 1 Diabetes
06/14 FASTING WITH DIABETES : Novo Nordisk Aims To Help Patients During Ramadan
06/14 NOVO NORDISK A/S : Victoza® significantly reduced the risk of major cardiovascul..
06/14 NOVO NORDISK A/S : Can a bunch of doctors keep an $8 billion secret? Not on Twit..
06/14 NOVO NORDISK A/S : Study Finds Victoza® Significantly Reduced the Risk of Heart ..
06/13 NOVO NORDISK A/S : presents new findings for Tresiba and semaglutide
06/13 NOVO NORDISK A/S : Faster-acting insulin aspart showed a statistically significa..
06/13 NOVO NORDISK A/S : Sewer pact aids Novo expansion
06/13 NOVO NORDISK A/S : Faster-acting insulin aspart showed a statistically significa..
06/13 NOVO NORDISK A/S : - Share repurchase programme
06/13 NOVO NORDISK A/S : Tresiba® (insulin degludec injection U-100) demonstrated sign..
06/13 NOVO NORDISK A/S : Semaglutide demonstrated superior improvements in glycaemic c..
06/09 NOVO NORDISK A/S : Reports Outline DNA Research Findings from Novo Nordisk
06/09 NOVO NORDISK A/S : Researchers at Novo Nordisk Report New Data on Immunoglobulin..
06/08 DIABETES : the scourge of city living
06/06 NOVO NORDISK A/S : - Share repurchase programme
06/06 NOVO NORDISK A/S : to present 53 abstracts at 76th Annual American Diabetes Asso..
06/06 NOVO NORDISK A/S : to present 53 abstracts at 76th Annual American Diabetes Asso..
06/03 NOVO NORDISK A/S : Early response to Saxenda results in improvement in weight lo..
06/03 NOVO NORDISK A/S : IDegLira receives positive 16-0 vote in favour of approval fr..
06/03 NOVO NORDISK A/S : Three-year data show early response to Saxenda® resulted in i..
06/02 NOVO NORDISK A/S : Researchers from Novo Nordisk Describe Findings in Pneumonia ..
06/02 NOVO NORDISK A/S : Studies from Novo Nordisk in the Area of Pharmacokinetics Des..
06/02 NOVO NORDISK A/S : IDegLira receives unanimous 16-0 vote in favor of approval fr..
05/31 NOVO NORDISK A/S : Danish companies keen to take part in make in india
05/30 NOVO NORDISK A/S : In Egypt, Novo Nordisk leads the fight in the global war on d..
05/30 NOVO NORDISK A/S : - Share repurchase programme
05/30 NOVO NORDISK A/S : Semaglutide demonstrated superior glycaemic control vs insuli..
05/29 TIZI OUZOU : Prime Minister lays foundation stone of Novo Nordisk factory's exte..
05/25 NOVO NORDISK A/S : IDegLira receives positive 16-0 vote in favour of approval fr..
05/25 NOVO NORDISK A/S : European shares hit new 4-week high
05/24 NOVO NORDISK A/S : IDegLira receives positive 16-0 vote in favour of approval fr..
05/23 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
05/20 NOVO NORDISK A/S : FDA posts briefing materials prior to Advisory Committee meet..
05/19 NOVO NORDISK A/S : Team Novo Nordisk doing more than just racing
05/17 NOVO NORDISK A/S : files for regulatory approval in the US of long-acting factor..
05/17 NOVO NORDISK A/S : Iran to join insulin producers club in four years
05/16 NOVO NORDISK A/S : files for regulatory approval in the US of long-acting factor..
05/16 EMISPHERE TECHNOLOGIES : Reports First Quarter 2016 Financial Results
05/16 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( DKK)
Sales 2016 114 734 M
EBIT 2016 49 682 M
Net income 2016 38 844 M
Finance 2016 10 619 M
Yield 2016 1,91%
P/E ratio 2016 24,52
P/E ratio 2017 22,03
EV / Sales 2016 6,54x
EV / Sales 2017 6,04x
Capitalization 760 548 M
More Financials
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 402  DKK
Spread / Average Target 6,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Rebien Sørensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Alan C. Moses Global Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-5.53%113 265
JOHNSON & JOHNSON21.16%342 345
PFIZER INC.13.60%222 398
ROCHE HOLDING LTD.-9.99%215 597
NOVARTIS AG-5.30%214 061
MERCK & CO., INC.10.62%161 736
More Results